R&D agreements in Life Sciences
20 March 2020Health/pharma, therapeutic area
Assistance of a biotech company which designs and develops vectors facilitating the targeting and delivery of therapeutic or imaging agents during the negotiation of a strategic R&D and licensing agreement in the field of the treatment of neurodegenerative pathologies with the subsidiary of a global big pharma.
Strategy
Close assistance in the negotiation of all contractual aspects, particularly sensitive intellectual property clauses, with a view of preventing and limiting litigation risks.
Achievements
Conclusion of a strategic agreement for the company: this partnership falls into the client’s strategy to use its technology to conclude R&D agreements with biopharmaceutical companies. The objective is to create new patentable chemical entities based on the vectorization of its partners’ drug candidates.